HMGB1 is able to bind to the toll-like receptor 4 (TLR4) on DC, which allows tumor-derived antigens to be processed and presented along with MHC and costimulatory molecules on the surface of DC [216]. The gene discussed is HMGB1; the disease is neoplasm.